(PharmaNewsWire.Com, November 09, 2021 ) According to the new market research report, “Process Analytical Technology Market by Technique (Spectroscopy, Chromatography), Measurement (On-Line, In-Line, At-Line), Products and Services (Analyzers, Probes & Sensors), End – User (Pharmaceutical Manufacturers, CRO & CMO) – Global Forecast to 2021″, provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.
Browse and in-depth TOC on “Process Analytical Technology Market”
Market growth is primarily driven by factors such as government regulations on drug safety, need for manufacturing process efficiency leading to quality improvement, and technological advancements in analytical devices. Other factors supporting market growth include an increase in R&D spending by pharma and biopharma companies and increasing government investments in emerging countries. The emerging markets are also expected to offer plenty of growth opportunities for players in the market.
Global Leading Players:
Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Danaher Corporation (U.S.) are the leading players in the global process analytical technology market. The strong position of these companies in the market can primarily be attributed to their global presence and broad product portfolio. Other major players in the market include Bruker Corporation (U.S.), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), ABB Ltd. (U.S.), Carl Zeiss AG (Germany), Emerson Electric Co. (U.S.), and Mettler-Toledo International Inc. (U.S.).
Different Growth Strategies Adopted by Them:
Companies in the process analytical technology market are majorly focusing on product launches for strengthening their market share; this strategy accounted for 63.5% of the total number of strategic developments undertaken by key players in this market.
Thermo Fisher Scientific Inc. dominated the global PAT market in 2016. The company offers analytical technologies through its analytical instruments business segments, which cater to the markets in developed as well as developing countries. The company mainly focuses on product launches as its key growth strategy. The company launched many products between January 2016 and July 2016, including the Vanquish Flex Binary UHPLC system, Q Exactive BioPharma, Exactive GC Orbitrap GC-MS, Dionex Chromeleon 7.2 Chromatography Data System, and MAbPac RP column.
Agilent Technologies, Inc. held the second position in the global PAT market in 2016. Agilent Technologies operates under three business segments, namely, Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The company focuses on organic growth strategies such as product launches and expansions in various territories to keep up with its competitors. Agilent offers a broad portfolio of PAT solutions and has a vast geographic presence with distribution channels across the Americas, Europe, Asia-Pacific, and the Middle East.
Danaher Corporation held the third position in the global PAT market. The company offers its process analytical technology solutions through its subsidiary, AB Sciex LLC, (U.S.). It focuses on strategies such as partnerships and collaborations to enhance its technical strengths as well as secure its market position. The company also focuses on product launches to improve its portfolio. The company has a global presence in developed regions such as North America and Europe as well as developing regions such as Asia-Pacific and Latin America.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
